2,373 results on '"Grant, Steven"'
Search Results
2. Russian Children’s Literature and Culture , and: Encyclopedia of Children and Childhood: In History and Society , and: Children’s World: Growing Up in Russia, 1890–1991 , and: Russkie deti: Osnovy narodnoi pedagogiki. Illiustrirovannaia entsiklopediia (review)
3. Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
4. Antenatal screening for fetal structural anomalies – Routine or targeted practice?
5. Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells
6. Final Report: Preparation and Testing of LAW Matrix Glasses to Support WTP Property-Composition Model Development, VSL-04R4480-1, Rev. 0 (April 2004)
7. Meaningful associations in the adolescent brain cognitive development study
8. Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies
9. The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence
10. Ventilator‐assisted preoxygenation in an aeromedical retrieval setting.
11. #1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma
12. IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB– and caspase-8–dependent mechanisms
13. Nomen est Omen: Onomastics and Russian Revolutionaries
14. Proportionate Affine Projection Algorithms for Block-sparse System Identification
15. Block Sparse Memory Improved Proportionate Affine Projection Sign Algorithm
16. Proportionate Adaptive Filtering for Block Sparse System Identification
17. An Improved Variable Step-size Zero-point Attracting Projection Algorithm
18. Myeloid Targeted Human MLL-ENL and MLL-AF9 Induces cdk9 and bcl2 Expression in Zebrafish Embryos.
19. Revisiting Ratify: Daunorubicin 60 Mg/m2 Vs 90 Mg/m2 in Previously Untreated FLT3mut Acute Myeloid Leukemia
20. CUX1 mut Acute Myeloid Leukemia As a Distinct Biological Entity: An Analysis of Clinical Outcomes and Implications
21. A New Variable Step-size Zero-point Attracting Projection Algorithm
22. An Improved Variable Step-size Affine Projection Sign Algorithm for Echo Cancellation
23. Image processing and analysis methods for the Adolescent Brain Cognitive Development Study
24. Azaphosphinate Dyes: A Low Molecular Weight Near‐Infrared Scaffold for Development of Photoacoustic or Fluorescence Imaging Probes.
25. Presbyterians and Their Elders
26. Single Atom Stabilization of Phosphinate Ester‐Containing Rhodamines Yields Cell Permeable Probes for Turn‐On Photoacoustic Imaging
27. FIGURE 4 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
28. FIGURE 5 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
29. Supplementary Table 6 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
30. FIGURE 1 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
31. Supplementary Figure 5 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
32. Supplementary Table 1 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
33. Supplementary Figure 1 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
34. FIGURE 3 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
35. Supplementary Figure 2 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
36. Supplementary Figure 6 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
37. Supplementary Table 5 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
38. Supplementary Table 3 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
39. Supplementary Figure 3 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
40. Supplementary Movie 1 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
41. Supplementary Figure 7 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
42. Supplementary Figure 9 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
43. Supplementary Table 2 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
44. Supplementary Figure 4 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
45. Supplementary Movie 1 Legend from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
46. Supplementary Figure 8 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
47. Supplementary Table 4 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
48. Data from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
49. Supplementary Methods from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
50. FIGURE 2 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.